Please use this identifier to cite or link to this item:

Titleβ-cyclodextrin/isopentyl caffeate inclusion complex: synthesis, characterization and antileishmanial activity
Author(s)Marques, Carine S. F.
Barreto, Nathalia S.
Oliveira, Simone S. C. de
Santos, André L. S.
Branquinha, Marta H.
Sousa, Damião P. de
Castro, Mayara
Andrade, Luciana N.
Pereira, Matheus M.
Silva, Classius F. da
Chaud, Marco V.
Jain, Sona
Fricks, Alini T.
Souto, Eliana B.
Severino, Patrícia
KeywordsIsopentyl caffeate
Inclusion complex
Issue date2020
CitationMarques, Carine S. F.; Barreto, Nathalia S.; Oliveira, Simone S. C. de; Santos, André L. S.; Branquinha, Marta H.; Sousa, Damião P. de; Castro, Mayara; Andrade, Luciana N.; Pereira, Matheus M.; Silva, Classius F. da; Chaud, Marco V.; Jain, Sona; Fricks, Alini T.; Souto, Eliana; Severino, Patricia, -cyclodextrin/isopentyl caffeate inclusion complex: synthesis, characterization and antileishmanial activity. Molecules, 25(18), 4181, 2020
Abstract(s)Isopentyl caffeate (ICaf) is a bioactive ester widely distributed in nature. Our patented work has shown promising results of this molecule against Leishmania. However, ICaf shows poor solubility, which limits its usage in clinical settings. In this work, we have proposed the development of an inclusion complex of ICaf in -cyclodextrin (-CD), with the aim to improve the drug solubility, and thus, its bioavailability. The inclusion complex (ICaf:-CD) was developed applying three distinct methods, i.e., physical mixture (PM), kneading (KN) or co-evaporation (CO) in different molar proportions (0.25:1, 1:1 and 2:1). Characterization of the complexes was carried out by thermal analysis, Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and molecular docking. The ICaf:-CD complex in a molar ratio of 1:1 obtained by CO showed the best complexation and, therefore, was selected for further analysis. Solubility assay showed a marked improvement in the ICaf:-CD (CO, 1:1) solubility profile when compared to the pure ICaf compound. Cell proliferation assay using ICaf:-CD complex showed an IC50 of 3.8 and 2.7 µg/mL against L. amazonesis and L. chagasi promastigotes, respectively. These results demonstrate the great potential of the inclusion complex to improve the treatment options for visceral and cutaneous leishmaniases.
Publisher version
AccessOpen access
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_53901_1.pdf4,2 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID